REVOLUTION Medicines Garners $25,000,000 Series A Funding

  • Feed Type
  • Date
    12/22/2016
  • Company Name
    REVOLUTION Medicines
  • Mailing Address
    Undisclosed Redwood City, CA 94062 USA
  • Company Description
    REVOLUTION Medicines’ first drug candidates exploit and improve upon the properties of amphotericin B, a powerful, broad-spectrum antifungal compound found in nature that has avoided generating significant drug resistance in 50 years of clinical use.
  • Website
    Undisclosed
  • Transaction Type
    Venture Equity
  • Transaction Amount
    $25,000,000
  • Transaction Round
    Series A
  • Proceeds Purposes
    Proceeds from this expanded round will support the company as it continues advancing its discovery programs toward clinical development.
  • M&A Terms
  • Venture Investor
    The Column Group
  • Venture Investor
    Third Rock Ventures

Trending on Xconomy